Skip to content
Clinical Trials – home

Sørlandet sykehus Kristiansand

Verified siteinfo

Norway Egsveien 100, 4615 Kristiansand, Norway

  • 20 trials recruiting
  • Ovarian cancer · Juvenile idiopathic arthritis · Neoplasm malignant
  • Adults and children

About Specializations

Sørlandet sykehus Kristiansand in Kristiansand, Norway specialises in clinical trials of conditions such as Ovarian cancer, Juvenile idiopathic arthritis, Neoplasm malignant, Prostate cancer metastatic, and other specialisations. This site conducts important research.

Main research areas of the site

Viral Respiratory Tract Infections

The medical center is at the forefront of research in viral respiratory tract infections, focusing on innovative approaches to treatment. The center's research aims to evaluate the efficacy and safety of discontinuing antibiotic therapy in patients with confirmed viral infections, challenging traditional treatment paradigms.

  • Antibiotic Therapy Discontinuation
  • Non-Inferiority to Continuation
  • Patient Safety and Outcomes

This research contributes to a deeper understanding of the role of antibiotics in viral infections, potentially leading to more targeted and effective treatment protocols.

Juvenile Idiopathic Arthritis

Specializing in juvenile idiopathic arthritis, the center is dedicated to improving therapeutic strategies for young patients. The research focuses on assessing the impact of different treatment withdrawal strategies on the risk of disease flares, providing insights into maintaining disease remission.

  • Treatment Withdrawal Strategies
  • Risk of Flares
  • Sustained Inactive Disease

By exploring these strategies, the center aims to enhance the quality of life for children and adolescents, offering hope for long-term disease management without continuous medication.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Egsveien 1004615 KristiansandNorway
Recruiting now
20 trials
Conditions studied
44
Partner status
Verified site

More sites in KristiansandNorway

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

40 clinical trials

Cachexia

Recruiting

A Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Visugromab
  • Sponsor:CatalYm GmbH

Study of Ifinatamab Deruxtecan and Chemotherapy for Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Daiichi Sankyo Inc.

A double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:BI 1015550
  • Sponsor:Boehringer Ingelheim Espana S.A.

Rinatabart Sesutecan plus bevacizumab vs standard care as maintenance for recurrent platinum‑sensitive ovarian cancer after second‑line chemotherapy

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Genmab A/S

Ovarian cancer

Recruiting

A study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Merck Sharp & Dohme LLC

Major depression+1

Recruiting

A study on ketamine maintenance treatment for patients with treatment-resistant major depression disorder

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Ketamine Hydrochloride
  • Sponsor:Ostfold Hospital Trust

Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Ferric Derisomaltose
  • Sponsor:Pharmacosmos A/S

Migraine

Recruiting

Study on Reducing Chronic Migraine Days with CGRP Antibodies and Botulinum Toxin A in Adults Aged 18-70

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Erenumab
  • Sponsor:Oslo University Hospital HF

Study on the Effects of ILB and Riluzole for Patients with Amyotrophic Lateral Sclerosis (ALS)

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Riluzole
  • Sponsor:Oslo University Hospital HF

Study on Dabrafenib, Trametinib, and Imatinib for Patients with Rare and Hard-to-Treat Cancers

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Dabrafenib
  • Sponsor:Oslo University Hospital HF

Study on the Effectiveness of Tepotinib and Drug Combination for Patients with Advanced Cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Oslo University Hospital HF

Study on Treatment Strategies for Children and Adolescents with Juvenile Idiopathic Arthritis Using Methotrexate and Drug Combination

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years
  • Substances:Adalimumab
  • Sponsor:Oslo University Hospital HF
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.